We are live on
!
Find out more
BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
1-Year Est. Return
51.97%
This Fund
S&P 500
This Quarter
Est. Return
+32.67%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
–
AUM
$601M
AUM Growth
-$356M
(-37%)
Cap. Flow
-$490M
Cap. Flow
% of AUM
-81.42%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
462
New
190
Increased
14
Reduced
95
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
THS
Treehouse Foods
THS
|
+$5.17M |
| 2 |
NewMarket
NEU
|
+$5.15M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$4.93M |
| 4 |
Republic Services
RSG
|
+$4.8M |
| 5 |
Progressive
PGR
|
+$4.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$13.2M |
| 2 |
Vistra
VST
|
+$12.6M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$12.1M |
| 4 |
DexCom
DXCM
|
+$11.8M |
| 5 |
HP
HPQ
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.62% |
| 2 | Technology | 17.79% |
| 3 | Consumer Staples | 15.06% |
| 4 | Industrials | 11.35% |
| 5 | Consumer Discretionary | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
26
Novo Nordisk
NVO
$196B
| $4.64M | 0.77% |
+141,648
| New | +$4.52M |
|
27
Sherwin-Williams
SHW
$87.8B
| $4.62M | 0.77% |
+23,982
| New | +$4.32M |
|
28
Charter Communications
CHTR
$18.3B
| $4.61M | 0.77% |
+9,038
| New | +$4.58M |
|
29
Booz Allen Hamilton
BAH
$8.56B
| $4.59M | 0.76% |
+59,062
| New | +$4.47M |
|
30
DaVita
DVA
$14.6B
| $4.59M | 0.76% |
58,005
-88,995
| -61% | -$6.95M |
|
|
LKFT
31
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $4.57M | 0.76% |
23,180
-24,991
| -52% | -$5.18M |
|
32
Jazz Pharmaceuticals
JAZZ
$15.8B
| $4.57M | 0.76% |
41,445
-50,142
| -55% | -$5.54M |
|
33
ASML
ASML
$658B
| $4.57M | 0.76% |
12,403
+10,020
| +420% | +$3.15M |
|
|
CSOD
34
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $4.56M | 0.76% |
118,145
-15,701
| -12% | -$552K |
|
35
Expeditors International
EXPD
$22.3B
| $4.54M | 0.75% |
+59,670
| New | +$4.36M |
|
36
Simpson Manufacturing
SSD
$7.91B
| $4.51M | 0.75% |
53,430
-30,035
| -36% | -$2.21M |
|
37
Becton Dickinson
BDX
$46.9B
| $4.5M | 0.75% |
+19,296
| New | +$4.65M |
|
38
Gartner
IT
$10.1B
| $4.44M | 0.74% |
36,584
-22,894
| -38% | -$2.65M |
|
39
Dollar General
DG
$28.2B
| $4.44M | 0.74% |
+23,294
| New | +$4.22M |
|
|
HRC
40
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.43M | 0.74% |
+40,402
| New | +$4.23M |
|
41
Biogen
BIIB
$29.8B
| $4.42M | 0.73% |
16,501
-21,741
| -57% | -$6.54M |
|
42
Yum China
YUMC
$16.6B
| $4.41M | 0.73% |
+91,657
| New | +$4.32M |
|
43
Ubiquiti
UI
$33.2B
| $4.39M | 0.73% |
+25,172
| New | +$4.22M |
|
44
Bio-Techne
TECH
$11.2B
| $4.35M | 0.72% |
+65,912
| New | +$3.95M |
|
45
Waters Corp
WAT
$36.8B
| $4.32M | 0.72% |
+23,967
| New | +$4.53M |
|
46
New Oriental
EDU
$9.4B
| $4.3M | 0.72% |
33,020
-51,853
| -61% | -$6.32M |
|
47
Jack Henry & Associates
JKHY
$11.1B
| $4.3M | 0.72% |
+23,358
| New | +$4.07M |
|
48
Usana Health Sciences
USNA
$422M
| $4.28M | 0.71% |
58,294
+1,355
| +2% | +$106K |
|
49
TriNet
TNET
$3.24B
| $4.27M | 0.71% |
70,107
-33,730
| -32% | -$1.69M |
|
50
Zimmer Biomet
ZBH
$18.5B
| $4.27M | 0.71% |
36,829
-81,291
| -69% | -$9.37M |
|
Similar funds
FC
NISOA
UMA
HS
DFG
SRCM
OFM
SAM
Bogle Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Bogle Investment Management held 462 positions worth $601M, down 37% from $957M the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Bogle Investment Management withdrew a net $490M in Q2 2020, closing 160 positions and reducing 95 holdings. Its most notable exit was HP, an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Bogle Investment Management opened a new position in Treehouse Foods worth $4.64M.
- Bogle Investment Management's largest Q2 2020 buy was Treehouse Foods: 106,025 shares worth $4.64M.
- Bogle Investment Management added most to ASML in Q2 2020, an estimated $3.15M increase.
- Bogle Investment Management's biggest Q2 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $13.2M.
- Bogle Investment Management fully exited HP in Q2 2020, selling an estimated $11.7M.
- Bogle Investment Management's ten largest holdings make up 8.8% of its $601M portfolio in Q2 2020.
- Bogle Investment Management opened 190 new positions and closed 160 in Q2 2020.
- Bogle Investment Management's portfolio value fell 37% quarter-over-quarter to $601M.
Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.